reference/2528365

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2528365

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	6
issn	2168-6068
issueIdentifier	5
pageRange	555-6
publicationName	JAMA Dermatology
startingPage	555
bibliographicCitation	Coleman KM, Gudjonsson JE, Stecher M. Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1α, for the Treatment of Psoriasis. JAMA Dermatol. 2015 May;151(5):555–6. doi: 10.1001/jamadermatol.2014.5391. PMID: 25715176.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1253f1fee3e56fce3b804c6ad8b8836d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e08102b9754ea0254645437108aef527 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_31f58ba604aa8da76e5a1e8fa9d7dc76
date	2015-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/25715176 https://doi.org/10.1001/jamadermatol.2014.5391
isPartOf	https://portal.issn.org/resource/ISSN/2168-6068 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/40862
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Open-Label Trial of MABp1, a True Human Monoclonal Antibody Targeting Interleukin 1α, for the Treatment of Psoriasis
discusses	http://id.nlm.nih.gov/mesh/M000608393 http://id.nlm.nih.gov/mesh/M0011501 http://id.nlm.nih.gov/mesh/M0001357
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011565Q000378 http://id.nlm.nih.gov/mesh/D011565Q000188 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D053582Q000378
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000911Q000097 http://id.nlm.nih.gov/mesh/D016896 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D004334 http://id.nlm.nih.gov/mesh/D006207 http://id.nlm.nih.gov/mesh/D007279 http://id.nlm.nih.gov/mesh/D005500

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID28988

Total number of triples: 36.